Skip to main content

#Cambodia's 4th #death of #H5N1 #birdflu recorded in 2025

PHNOM PENH, May 28 (Xinhua) -- An 11-year-old boy from western Cambodia's Kampong Speu province had died of H5N1 human avian influenza, becoming the fourth human death from the virus so far this year, the Ministry of Health said in a press statement released on Wednesday.

"A laboratory result from the Pasteur Institute of Cambodia showed on May 27, 2025, that the boy was positive for the H5N1 virus," the statement said.

The ill-fated boy lived in Samraong Tong district's Srey Sampoung village.

"According to queries, chickens and ducks near the patient's house had gotten sick and died subsequently a week before the boy fell ill," the statement said.

Health authorities are looking into the source of the infection and examining any suspected cases or people who have been in contact with the victim in order to prevent an outbreak in the community, it added.

The Southeast Asian country recorded a total of four human cases of H5N1 so far this year, with all deaths, and all patients reportedly had a history of recent exposure to sick or dead poultry prior to their illness.

H5N1 influenza is a flu that normally spreads between sick poultry, but can sometimes spread from poultry to humans. Its symptoms include fever, cough, runny nose, and severe respiratory illness.

The Ministry of Health called on people to be extra vigilant and not to eat ill or dead poultry, saying that bird flu still threatens people's health.

From 2003 to date, there were 76 cases of human infection with H5N1 influenza, including 47 deaths in the kingdom, according to the Ministry of Health

Source: Xinhua, https://english.news.cn/asiapacific/20250528/f6f6d89a657d4997a6df2f4b9ad12ba6/c.htmlhttps://english.news.cn/asiapacific/20250528/f6f6d89a657d4997a6df2f4b9ad12ba6/c.html

____

Comments

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...